This program features topics relevant to the multidisciplinary team approach to caring for patients receiving CAR T-cell therapies and their relatives.
This program features topics relevant to the multidisciplinary team approach to caring for patients receiving CAR T-cell therapies and their relatives.
The CAR (Chimeric Antigen Receptor) T-cell therapies: a resource for healthcare professionals learning program was made possible by an educational grant from Celgene / Bristol Myers Squibb Company, Janssen-Cilag AG, Novartis and Kite Gilead.
Projekt finansowany z programu Horyzont 2020 wspierającego badania naukowe i innowacje w Unii Europejskiej (umowa o dotację nr 965241).
© Copyright 2020-2025 EuroGCT and contributing authors